How Rising Demand for Precision Medicine is Fueling the IVD Market’s Fastest Growth In Vitro Diagnostics Market In Vitro ...
The in vitro diagnostic has been awarded a breakthrough ... director of the FDA's Centre for Devices and Radiological health, said the new test could do away with the need for "time-consuming ...
Despite insufficient evidence to support direct-to-consumer genetic testing in routine clinical care, cardiovascular ...
8d
Zacks Investment Research on MSNQuidelOrtho Unveils Results Manager System to Streamline TestingQuidelOrtho QDEL recently launched the Results Manager System, a cutting-edge solution designed to streamline diagnostic data management and improve workflow efficiency in laboratories. This ...
Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate WAVEâ„¢ system and positive blood culture ...
Hosted on MSN2mon
ICMR proposes new diagnostic tests in PHCsThe list enumerates the minimum number of tests that should be available ... of an NEDL to facilitate the availability of in-vitro diagnostics across the various tiers of the healthcare pyramid ...
A handful of these tests, both protein- and DNA-based, have subsequently been approved for in vitro diagnostic testing (Table 1). In this section, we outline some of the pharmacogenetic tests ...
Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation ... such as statements relating to the Company’s inFoods® IBS test and other diagnostic tests, international regulatory ...
Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...
Market was valued at USD 336.07 million in 2024 and is expected to reach USD 441.23 million by 2033, growing at a CAGR of 4.60% during the forecast period. The market is experiencing substantial ...
The three diagnostic tests for identifying genetic mutations associated with SMA met new European Union regulatory requirements.
Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results